ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 92 filers reported holding ADMA BIOLOGICS INC in Q1 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $671,608 | -3.0% | 187,600 | 0.0% | 0.00% | – |
| Q2 2023 | $692,244 | +88.1% | 187,600 | +68.7% | 0.00% | – |
| Q1 2023 | $368,072 | -14.7% | 111,200 | 0.0% | 0.00% | – |
| Q4 2022 | $431,456 | +285.2% | 111,200 | +141.7% | 0.00% | – |
| Q3 2022 | $112,000 | +124.0% | 46,000 | +82.5% | 0.00% | – |
| Q2 2022 | $50,000 | -65.3% | 25,200 | -69.3% | 0.00% | – |
| Q1 2021 | $144,000 | -10.6% | 82,000 | -0.8% | 0.00% | – |
| Q4 2020 | $161,000 | -37.8% | 82,700 | -23.8% | 0.00% | – |
| Q3 2020 | $259,000 | -52.2% | 108,500 | -41.3% | 0.00% | – |
| Q2 2020 | $542,000 | +107.7% | 184,900 | +104.3% | 0.00% | – |
| Q1 2020 | $261,000 | +177.7% | 90,500 | +283.5% | 0.00% | – |
| Q4 2019 | $94,000 | -10.5% | 23,600 | 0.0% | 0.00% | – |
| Q3 2019 | $105,000 | +15.4% | 23,600 | 0.0% | 0.00% | – |
| Q2 2019 | $91,000 | – | 23,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
| Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
| Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
| Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
| Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
| MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
| Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
| PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
| 683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |